CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues.
paper
Cited
Public
Unavailable
- Authors
- Kraus, Damian M; Elliott, Gary S; Chute, Hilary; Horan, Thomas; Pfenninger, Karl H; Sanford, Staci D; Foster, Stephen; Scully, Sheila; Welcher, Andrew A; Holers, V Michael
- Year
- 2006
- Journal
- Journal of immunology (Baltimore, Md. : 1950)
- PMID
- 16547280
- DOI
- 10.4049/jimmunol.176.7.4419
In this study, we describe the identification and in vitro functional activity of a novel multiple domain complement regulatory protein discovered based on its homology to short consensus repeat (SCR)-containing proteins of the regulators of complement activation (RCA) gene family. The rat cDNA encodes a predicted 388-kDa protein consisting of 14 N-terminal CUB domains that are separated from each other by a SCR followed by 15 tandem SCR domains, a transmembrane domain, and a short cytoplasmic tail. This protein is the homolog of the human protein of unknown function called the CUB and sushi multiple domains 1 (CSMD1) protein. A cloning strategy that incorporates the two C-terminal CUB-SCR domains and 12 of the tandem SCR repeats was used to produce a soluble rat CSMD1 protein. This protein blocked classical complement pathway activation in a comparable fashion with rat Crry but did not block alternative pathway activation. Analysis of CSMD1 mRNA expression by in situ hybridization and immunolabeling of neurons indicates that the primary sites of synthesis are the developing CNS and epithelial tissues. Of particular significance is the enrichment of CSMD1 in the nerve growth cone, the amoeboid-leading edge of the growing neuron. These results suggest that CSMD1 may be an important regulator of complement activation and inflammation in the developing CNS, and that it may also play a role in the context of growth cone function.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Clonal Dynamics of Hematopoiesis in Aplastic Anemia after Immunosuppression and Eltrombopag. | Kaya DE et al. | — | 2026 | → |
| Identifying a Common Autoimmune Gene Core as a Tool for Verifying Biological Significance and Applicability of Polygenic Risk Scores. | Shchekina VS et al. | — | 2026 | → |
| A spatial atlas of the complement system uncovers unique expression patterns in postnatal brain development in mice. | Zhang Y et al. | — | 2025 | → |
| Biomarkers in Schizophrenia: Current Approaches and New Developments-A Literature Review. | Sierakowska A et al. | — | 2025 | → |
| Genetic Parameters, Linear Associations, and Genome-Wide Association Study for Endotoxin-Induced Cortisol Response in <i>Holstein heifers</i>. | Galindo BA et al. | — | 2025 | → |
| Genomic insights into the genetic diversity and genetic basis of body height in endangered Chinese Ningqiang ponies. | Han J et al. | — | 2025 | → |
| <i>CSMD1</i> as a causative gene of developmental and epileptic encephalopathy and generalized epilepsies. | Zhang W et al. | — | 2025 | → |
| Potential Association of the <i>CSMD1</i> Gene with Moderate Intellectual Disability, Anxiety Disorder, and Obsessive-Compulsive Personality Traits. | Musumeci A et al. | — | 2025 | → |
| The complement cascade in Alzheimer's disease: modern implications of an ancient immune protagonist. | Papavergi MT et al. | — | 2025 | → |
| The role of complement in normal pregnancy and preeclampsia. | Burwick RM et al. | — | 2025 | → |
| The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans. | Byrne RAJ et al. | — | 2025 | → |
| Uncovering potential causal genes for undiagnosed congenital anomalies using an in-house pipeline for trio-based whole-genome sequencing. | Kim JM et al. | — | 2025 | → |
| An asymptomatic male individual carrying a 5.72 Mb <i>de novo</i> deletion in 8p23.2‑p23.3: A case report. | Keramida C et al. | — | 2024 | → |
| A novel locus in <i>CSMD1</i> gene is associated with increased susceptibility to severe malaria in Malian children. | Damena D et al. | — | 2024 | → |
| Copy number variations in autistic children. | Alhazmi S et al. | — | 2024 | → |
| CSMD1 regulates brain complement activity and circuit development. | Baum ML et al. | — | 2024 | → |
| CSMD1 rs10503253 increases schizophrenia risk in a Tunisian population-group. | Mihoub O et al. | — | 2024 | → |
| From <i>Tg</i>O/GABA-AT, GABA, and T-263 Mutant to Conception of <i>Toxoplasma</i>. | Lykins J et al. | — | 2024 | → |
| Incidental detection of familial 8p23.2 microduplication encompassing CSMD1 associated with mosaic 46,XY,t(7;8)(q31.2;p23.1)/46,XY at amniocentesis in a pregnancy with no apparent phenotypic abnormality and a favorable outcome. | Chen CP et al. | — | 2024 | → |
| New Evidence for the Role of the Blood-Brain Barrier and Inflammation in Stress-Associated Depression: A Gene-Environment Analysis Covering 19,296 Genes in 109,360 Humans. | Gal Z et al. | — | 2024 | → |
| The complement system in neurodegenerative diseases. | Nimmo J et al. | — | 2024 | → |
| The Emerging Role of Immunoglobulins and Complement in the Stimulation of Neuronal Activity and Repair: Not as Simple as We Thought. | Veremeyko T et al. | — | 2024 | → |
| What's the situation with ocular inflammation? A cross-seasonal investigation of proteomic changes in ocular allergy sufferers' tears in Victoria, Australia. | Aydin E et al. | — | 2024 | → |
| Complement C4-deficient mice have a high mortality rate during PTZ-induced epileptic seizures, which correlates with cognitive problems and the deficiency in the expression of Egr1 and other immediate early genes. | Veremeyko T et al. | — | 2023 | → |
| Pleiotropic loci for cannabis use disorder severity in multi-ancestry high-risk populations. | Peng Q et al. | — | 2023 | → |
| Regulatory de novo mutations underlying intellectual disability. | De Vas MG et al. | — | 2023 | → |
| Cerebellar Agenesis and Bilateral Polimicrogyria Associated with Rare Variants of CUB and Sushi Multiple Domains 1 Gene (CSMD1): A Longitudinal Neuropsychological and Neuroradiological Case Study. | Costanzo F et al. | — | 2022 | → |
| Complement and microglia dependent synapse elimination in brain development. | Soteros BM et al. | — | 2022 | → |
| Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability. | Hatzimanolis A et al. | — | 2022 | → |
| Dysregulation of complement system in neuropsychiatric disorders: A mini review. | Sierra DP et al. | — | 2022 | → |
| Genome-wide screening of sex-biased genetic variants potentially associated with COVID-19 hospitalization. | Luo YS et al. | — | 2022 | → |
| Gut microbiome associations with host genotype vary across ethnicities and potentially influence cardiometabolic traits. | Boulund U et al. | — | 2022 | → |
| <i>CSMD1</i> Shows Complex Patterns of Somatic Copy Number Alterations and Expressions of mRNAs and Target Micro RNAs in Esophageal Squamous Cell Carcinoma. | Hu N et al. | — | 2022 | → |
| Maternal-fetal stress and DNA methylation signatures in neonatal saliva: an epigenome-wide association study. | Sharma R et al. | — | 2022 | → |
| New Insight into the human genetic diversity in North African populations by genotyping of SNPs in DRD3, CSMD1 and NRG1 genes. | Mestiri S et al. | — | 2022 | → |
| Novel genes bearing mutations in rare cases of early-onset ataxia with cerebellar hypoplasia. | Protasova MS et al. | — | 2022 | → |
| Targeted Sequencing of Alzheimer’s Disease Genes in Gujarat Cohort | Budhbhatti U et al. | — | 2022 | — |
| The Diverse Role of CUB and Sushi Multiple Domains 1 (CSMD1) in Human Diseases. | Ermis Akyuz E et al. | — | 2022 | → |
| Understanding the Role of the Gut Microbiome in Brain Development and Its Association With Neurodevelopmental Psychiatric Disorders. | Dash S et al. | — | 2022 | → |
| Whole Exome Sequencing Study in Isolated South-Eastern Moravia (Czechia) Population Indicates Heterogenous Genetic Background for Parkinsonism Development. | Kolarikova K et al. | — | 2022 | → |
| 8p23.2-pter Microdeletions: Seven New Cases Narrowing the Candidate Region and Review of the Literature. | Catusi I et al. | — | 2021 | → |
| Association of CSMD1 with Tumor Mutation Burden and Other Clinical Outcomes in Gastric Cancer. | Wang X et al. | — | 2021 | → |
| Complement Activation in the Central Nervous System: A Biophysical Model for Immune Dysregulation in the Disease State. | Peoples N et al. | — | 2021 | → |
| Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy. | Gialeli C et al. | — | 2021 | → |
| CUB and Sushi Multiple Domains (CSMD1) Gene Polymorphisms and Susceptibilities to Idiopathic Parkinson's Disease in Northern Chinese Han Population: A Case-Control Study. | Bai X et al. | — | 2021 | → |
| Genetic underpinnings of affective temperaments: a pilot GWAS investigation identifies a new genome-wide significant SNP for anxious temperament in ADGRB3 gene. | Gonda X et al. | — | 2021 | → |
| Host genetics influences the relationship between the gut microbiome and psychiatric disorders. | Martins-Silva T et al. | — | 2021 | → |
| Meta-analysis of global and high throughput public gene array data for robust vascular gene expression discovery in chronic rhinosinusitis: Implications in controlled release. | Khurana N et al. | — | 2021 | → |
| microRNAs Promoting Growth of Gastric Cancer Xenografts and Correlation to Clinical Prognosis. | Weidle UH et al. | — | 2021 | → |
| Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies. | de Klerk LK et al. | — | 2021 | → |
| mRNA Expression of the CUB and Sushi Multiple Domains 1 (<i>CSMD1</i>) and Its Serum Protein Level as Predictors for Psychosis in the Familial High-Risk Children and Young Adults. | Abd El Gayed EM et al. | — | 2021 | → |
| Optogenetic Stimulation of Prelimbic Pyramidal Neurons Maintains Fear Memories and Modulates Amygdala Pyramidal Neuron Transcriptome. | Laricchiuta D et al. | — | 2021 | → |
| Quantitative Proteomics Analysis of Susceptibility and Resilience to Stress in a Rat model of PTSD. | Duan J et al. | — | 2021 | → |
| Schizophrenia: Complement Cleaning or Killing. | Hogenaar JTT et al. | — | 2021 | → |
| The distribution of runs of homozygosity in the genome of river and swamp buffaloes reveals a history of adaptation, migration and crossbred events. | Macciotta NPP et al. | — | 2021 | → |
| The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets. | van Riet J et al. | — | 2021 | → |
| The Role of Csmd1 during Mammary Gland Development. | Burgess SJ et al. | — | 2021 | → |
| Whole-Exome Sequencing in a Cohort of High Myopia Patients in Northwest China. | Liu Y et al. | — | 2021 | → |
| A familial t(4;8) translocation segregates with epilepsy and migraine with aura. | Crippa M et al. | — | 2020 | → |
| A joint study of whole exome sequencing and structural MRI analysis in major depressive disorder. | Zhang Y et al. | — | 2020 | → |
| An Ultrahigh-Affinity Complement C4b-Specific Nanobody Inhibits In Vivo Assembly of the Classical Pathway Proconvertase. | Zarantonello A et al. | — | 2020 | → |
| Complement System in Brain Architecture and Neurodevelopmental Disorders. | Magdalon J et al. | — | 2020 | → |
| Genetic model of MS severity predicts future accumulation of disability. | Jackson KC et al. | — | 2020 | → |
| Genomic Association of Single Nucleotide Polymorphisms with Blood Pressure Response to Hydrochlorothiazide among South African Adults with Hypertension. | Masilela C et al. | — | 2020 | → |
| Immune dysregulation in depression: Evidence from genome-wide association. | Tubbs JD et al. | — | 2020 | → |
| The Co-existence of ADHD With Autism in Saudi Children: An Analysis Using Next-Generation DNA Sequencing. | Bogari NM et al. | — | 2020 | → |
| The complement system in schizophrenia: where are we now and what's next? | Woo JJ et al. | — | 2020 | → |
| The endogenous neuronal complement inhibitor SRPX2 protects against complement-mediated synapse elimination during development. | Cong Q et al. | — | 2020 | → |
| The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation. | Comer AL et al. | — | 2020 | → |
| Altered expression of the CSMD1 gene in the peripheral blood of schizophrenia patients. | Liu Y et al. | — | 2019 | → |
| Beyond C4: Analysis of the complement gene pathway shows enrichment for IQ in patients with psychotic disorders and healthy controls. | Holland JF et al. | — | 2019 | → |
| Host genetic determinants of the gut microbiota of wild mice. | Suzuki TA et al. | — | 2019 | → |
| Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers. | Cunningham PN et al. | — | 2019 | → |
| Novel MED12 variant in a multiplex Fragile X syndrome family: dual molecular etiology of two X-linked intellectual disabilities with autism in the same family. | Lahbib S et al. | — | 2019 | → |
| Rare mutations in the complement regulatory gene CSMD1 are associated with male and female infertility. | Lee AS et al. | — | 2019 | → |
| The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant population. | Stapleton CP et al. | — | 2019 | → |
| Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: A systematic review. | Prata DP et al. | — | 2019 | → |
| Accumulation of deleterious mutations in the domestic yak genome. | Xie X et al. | — | 2018 | → |
| A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease. | Porter T et al. | — | 2018 | → |
| Characterization of a teleost membrane-associated protein that is involved in the regulation of complement activation and bacterial infection. | Li MF et al. | — | 2018 | → |
| Genome-wide oxidative bisulfite sequencing identifies sex-specific methylation differences in the human placenta. | Gong S et al. | — | 2018 | → |
| Genomic convergence of locus-based GWAS meta-analysis identifies AXIN1 as a novel Parkinson's gene. | Saeed M | — | 2018 | → |
| Microglia and Beyond: Innate Immune Cells As Regulators of Brain Development and Behavioral Function. | Lenz KM et al. | — | 2018 | → |
| Novel potential inhibitors of complement system and their roles in complement regulation and beyond. | Gialeli C et al. | — | 2018 | → |
| Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions. | Amini-Nik S et al. | — | 2018 | → |
| The Role of Cell Adhesion Molecule Genes Regulating Neuroplasticity in Addiction. | Muskiewicz DE et al. | — | 2018 | → |
| A genetic association study of CSMD1 and CSMD2 with cognitive function. | Athanasiu L et al. | — | 2017 | → |
| Complement: A primer for the coming therapeutic revolution. | Barnum SR | — | 2017 | → |
| Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples. | Mandage R et al. | — | 2017 | → |
| Genetic, physiological and comparative genomic studies of hypertension and insulin resistance in the spontaneously hypertensive rat. | Coan PM et al. | — | 2017 | → |
| Genetic Predictors of Susceptibility to Dermatophytoses. | Abdel-Rahman SM | — | 2017 | → |
| Genetic Variants in CSMD1 Gene Are Associated with Cognitive Performance in Normal Elderly Population. | Stepanov V et al. | — | 2017 | → |
| Isolated chromosome 8p23.2‑pter deletion: Novel evidence for developmental delay, intellectual disability, microcephaly and neurobehavioral disorders. | Shi S et al. | — | 2017 | → |
| Loss of CSMD1 expression disrupts mammary duct formation while enhancing proliferation, migration and invasion. | Kamal M et al. | — | 2017 | → |
| Perinatal Asphyxia in Rat Alters Expression of Novel Schizophrenia Risk Genes. | Paparelli A et al. | — | 2017 | → |
| The role of complement inhibitors beyond controlling inflammation. | Blom AM | — | 2017 | → |
| Whole-exome sequencing associates novel <i>CSMD1</i> gene mutations with familial Parkinson disease. | Ruiz-Martínez J et al. | — | 2017 | → |
| Array-CGH diagnosis in ovarian failure: identification of new molecular actors for ovarian physiology. | Jaillard S et al. | — | 2016 | → |
| Copy number variations in Saudi family with intellectual disability and epilepsy. | Naseer MI et al. | — | 2016 | → |
| Effects of imatinib and nilotinib on the whole transcriptome of cultured murine osteoblasts. | Kirschner G et al. | — | 2016 | → |
| Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks. | Sherva R et al. | — | 2016 | → |
| Individual risk alleles of susceptibility to schizophrenia are associated with poor clinical and social outcomes. | Sakamoto S et al. | — | 2016 | → |
| Missense Variant in MAPK Inactivator PTPN5 Is Associated with Decreased Severity of Post-Burn Hypertrophic Scarring. | Sood RF et al. | — | 2016 | → |
| Multivariate Genetic Correlates of the Auditory Paired Stimuli-Based P2 Event-Related Potential in the Psychosis Dimension From the BSNIP Study. | Mokhtari M et al. | — | 2016 | → |
| Natural Selection in the Great Apes. | Cagan A et al. | — | 2016 | → |
| No association between the rs10503253 polymorphism in the CSMD1 gene and schizophrenia in a Han Chinese population. | Liu Y et al. | — | 2016 | → |
| Proteomic Analysis of Unbounded Cellular Compartments: Synaptic Clefts. | Loh KH et al. | — | 2016 | → |
| Schizophrenia genetics complements its mechanistic understanding. | Ruzzo EK et al. | — | 2016 | → |
| The analysis of association between SNCA, HUSEYO and CSMD1 gene variants and Parkinson's disease in Iranian population. | Shahmohammadibeni N et al. | — | 2016 | → |
| Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models. | Drgonova J et al. | — | 2015 | → |
| Anti-citrullinated peptide/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a meta-analysis of genome-wide association study in a Japanese population. | Terao C et al. | — | 2015 | → |
| Genome-wide Association Study of Postburn Scarring Identifies a Novel Protective Variant. | Sood RF et al. | — | 2015 | → |
| Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models. | Samsom JN et al. | — | 2015 | → |
| A non-parametric approach for detecting gene-gene interactions associated with age-at-onset outcomes. | Li M et al. | — | 2014 | → |
| Expression and replication studies to identify new candidate genes involved in normal hearing function. | Girotto G et al. | — | 2014 | → |
| Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1. | Xu W et al. | — | 2014 | → |
| Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. | Zhang R et al. | — | 2014 | → |
| Meta-analysis identifies loci affecting levels of the potential osteoarthritis biomarkers sCOMP and uCTX-II with genome wide significance. | Ramos YF et al. | — | 2014 | → |
| [Replicative association analysis of genetic markers of cognitive traits with Alzheimer's disease in a Russian population]. | Stepanov VA et al. | — | 2014 | → |
| The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males. | Koiliari E et al. | — | 2014 | → |
| A genome-wide survey of transgenerational genetic effects in autism. | Tsang KM et al. | — | 2013 | → |
| Evolution of the pygmy phenotype: evidence of positive selection fro genome-wide scans in African, Asian, and Melanesian pygmies. | Migliano AB et al. | — | 2013 | → |
| Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253. | Rose EJ et al. | — | 2013 | → |
| Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1. | Steen VM et al. | — | 2013 | → |
| Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253. | Donohoe G et al. | — | 2013 | → |
| Somatic mutations, allele loss, and DNA methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) gene reveals association with early age of diagnosis in colorectal cancer patients. | Shull AY et al. | — | 2013 | → |
| The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly. | Escudero-Esparza A et al. | — | 2013 | → |
| Three cases of isolated terminal deletion of chromosome 8p without heart defects presenting with a mild phenotype. | Burnside RD et al. | — | 2013 | → |
| Whole-genome sequencing in an autism multiplex family. | Shi L et al. | — | 2013 | → |
| Assessment of behaviors modeling aspects of schizophrenia in Csmd1 mutant mice. | Distler MG et al. | — | 2012 | → |
| Brief report: enrichment of associations in genes with fibrosis, apoptosis, and innate immunity functions with cardiac manifestations of neonatal lupus. | Ramos PS et al. | — | 2012 | → |
| Complement genetics, deficiencies, and disease associations. | Mayilyan KR | — | 2012 | → |
| Genetic modifiers of sickle cell disease. | Steinberg MH et al. | — | 2012 | → |
| Genetic predictors of susceptibility to cutaneous fungal infections: a pilot genome wide association study to refine a candidate gene search. | Abdel-Rahman SM et al. | — | 2012 | → |
| Genome-wide association studies of schizophrenia: does bigger lead to better results? | Bergen SE et al. | — | 2012 | → |
| GWAS reveals new recessive loci associated with non-syndromic facial clefting. | Camargo M et al. | — | 2012 | → |
| MBL and MASP-2 concentrations in serum and MBL2 promoter polymorphisms are associated to schizophrenia. | Foldager L et al. | — | 2012 | → |
| Molecular analysis of desmoid tumors with a high-density single-nucleotide polymorphism array identifies new molecular candidate lesions. | Erben P et al. | — | 2012 | → |
| Polymorphisms and noncardioembolic stroke in three case-control studies. | Luke MM et al. | — | 2012 | → |
| Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. | Molenaar JJ et al. | — | 2012 | → |
| Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study. | Swaminathan S et al. | — | 2011 | → |
| Structure and properties of the Ca(2+)-binding CUB domain, a widespread ligand-recognition unit involved in major biological functions. | Gaboriaud C et al. | — | 2011 | → |
| The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. | Håvik B et al. | — | 2011 | → |
| The molecular biology of head and neck cancer. | Leemans CR et al. | — | 2011 | → |
| Association analyses identify six new psoriasis susceptibility loci in the Chinese population. | Sun LD et al. | — | 2010 | → |
| Genome-wide association studies and the problem of relatedness among advanced intercross lines and other highly recombinant populations. | Cheng R et al. | — | 2010 | → |
| Genome-wide identification of susceptibility alleles for viral infections through a population genetics approach. | Fumagalli M et al. | — | 2010 | → |
| Identification of evidence suggestive of an association with peripheral arterial disease at the OSBPL10 locus by genome-wide investigation in the Japanese population. | Koriyama H et al. | — | 2010 | → |
| Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma. | Kamal M et al. | — | 2010 | → |
| The landscape of human genes involved in the immune response to parasitic worms. | Fumagalli M et al. | — | 2010 | → |
| The Sushi domains of GABAB receptors function as axonal targeting signals. | Biermann B et al. | — | 2010 | → |
| Addiction genetics and pleiotropic effects of common haplotypes that make polygenic contributions to vulnerability to substance dependence. | Uhl GR et al. | — | 2009 | → |
| A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. | Burgner D et al. | — | 2009 | → |
| An open access database of genome-wide association results. | Johnson AD et al. | — | 2009 | → |
| Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men. | Beuten J et al. | — | 2009 | → |
| Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. | Baranzini SE et al. | — | 2009 | → |
| Identification of a rare de novo three-way complex t(5;20;8)(q31;p11.2;p21) with microdeletions on 5q31.2, 5q31.3, and 8p23.2 in a patient with hearing loss and global developmental delay: case report. | Haj R et al. | — | 2009 | → |
| Addiction Reviews. Preface. | Uhl GR | — | 2008 | → |
| Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility. | Julià A et al. | — | 2008 | → |
| Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects. | Uhl GR et al. | — | 2008 | → |
| Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. | Lesch KP et al. | — | 2008 | → |
| Astrocyte-specific expression of a soluble form of the murine complement control protein Crry confers demyelination protection in the cuprizone model. | Briggs DT et al. | — | 2007 | → |
| Structure-based mapping of DAF active site residues that accelerate the decay of C3 convertases. | Kuttner-Kondo L et al. | — | 2007 | → |